1 completed, 1 recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Recruiting 1 |
Follow Platelet Aggregation Inhibitors: new trials by email Literature Review of Platelet Aggregation Inhibitors trials Research Report on Platelet Aggregation Inhibitors
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II Aspirin 81Mg Ec Tab twice daily for 7 days, Aspirin 40Mg Chew Tab twice daily for 7 days, Aspirin 162 mg EC Tab once daily for 7 days - Platelet Aggregation, Type 2 Diabetes | Phase 1 | Recruiting | Montreal Heart Institute | 30 | 2023-06-13 | 2025-12-03 |
| Pharmacodynamics and Pharmacokinetics of Aspirin Inhalation Powder With Non-Enteric-Coated Chewable Aspirin Aspirin - Platelet Aggregation Inhibitors | Phase 1 | Completed | Inova Health Care Services | 19 | 2019-07-16 | 2020-04-01 |
Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1)
Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1)
Aspirin (2) · Mastication (1)
Inova Health Care Services (1) · Montreal Heart Institute (1)
Canada (1) · United States (1)
Guillaume Marquis Gravel, MD, MSc (1)